Dialysis patients: need for optimisation of stroke prevention: The anticoagulants currently used to prevent strokes in dialysis patients with atrial fibrillation do not provide adequate protection for this group. This is the finding of a study led by Oliver Königsbrügge and Cihan Ay from the Department of Medicine I at MedUni Vienna and Vienna General […]
Covid-19 vaccination: thrombosis can be prevented by prompt treatment: A rare syndrome has been observed in people following vaccination against Covid-19. This involves thrombosis at unusual sites in the body, associated with a low thrombocyte (blood platelet) count and a clotting disorder. In medical jargon, this syndrome is referred to as VITT (vaccine-induced thrombotic thrombocytopenia). Doctors […]
High thrombotic risk in cancer patients receiving immunotherapy: In a study recently published in the leading journal “Blood”, Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the […]
Read More… from High thrombotic risk in cancer patients receiving immunotherapy
A new post-mortem study of patients who have died from COVID-19 found severe damage to the lungs and signs of blood clotting in major organs. Ten post-mortem examinations performed on patients with confirmed COVID-19 found that all patients had lung injuries and early scarring of the lungs as a result of the virus, as well […]
Read More… from Blood clots and lung injuries found patients who have died of Covid-19
Evidence from autopsies show that COVID-19 causes pulmonary arterial thrombosis and damages other organs as well as the lungs. COVID-19, the disease caused by SARS-CoV-2, not only may lead to severe pneumonia but also to thrombosis in the lungs and, subsequently, to multi organ failure involving kidneys, liver and pancreas. These are the findings of […]
Read More… from Lung damage, thrombosis and multi organ failure
The Top Journal Lancet Haematology recently published an international trial on a blood thinner to treat blood clots in children. Principal investigator was Christoph Male from the Department of Paediatrics and Adolescent Medicine, MedUni Vienna. He was now invited by Lancet Haematology to write a ‘Debate Article’ to give his view on the usefulness of […]
Read More… from Are clinical trials of anticoagulation feasible in children?
Medicines can have different effects in children than in adults, which is not just a question of the right dose. Yet, still only few pharmaceuticals have been specifically tested and approved for this patient group. For treatment of thrombosis, children currently receive Heparin and Vitamin K antagonists which are problematic and not approved for children. […]
Read More… from Thrombosis: Anticoagulant Rivaroxaban Soon Available for Children